SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-13-004795
Filing Date
2013-12-27
Accepted
2013-12-27 16:06:20
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 ohrp-10k_093013.htm 10-K 1023717
2 ex31-1.htm EX-31.1 14653
3 ex31-2.htm EX-31.2 15178
4 ex32-1.htm EX-32.1 6340
5 ex32-2.htm EX-32.2 6063
  Complete submission text file 0001387131-13-004795.txt   5145837

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ohrp-20130930.xml EX-101.INS 677042
7 XBRL SCHEMA FILE ohrp-20130930.xsd EX-101.SCH 37424
8 XBRL CALCULATION FILE ohrp-20130930_cal.xml EX-101.CAL 36802
9 XBRL DEFINITION FILE ohrp-20130930_def.xml EX-101.DEF 131003
10 XBRL LABEL FILE ohrp-20130930_lab.xml EX-101.LAB 279115
11 XBRL PRESENTATION FILE ohrp-20130930_pre.xml EX-101.PRE 216736
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-35963 | Film No.: 131300908
SIC: 2834 Pharmaceutical Preparations